The phosphodiesterase 5 inhibitor, KJH‐1002, reverses a mouse model of amnesia by activating a cGMP/cAMP response element binding protein pathway and decreasing oxidative damage

Lijun Zhang(Capital Medical University), Hyun Ok Yang(Bio-Medical Science (South Korea))
British Journal of Pharmacology
May 30, 2018
Cited by 33


Related Papers